108 related articles for article (PubMed ID: 10098732)
41. GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells.
Marchal JA; Prados J; Melguizo C; Gómez JA; Campos J; Gallo MA; Espinosa A; Arena N; Aránega A
Br J Cancer; 1999 Feb; 79(5-6):807-13. PubMed ID: 10070873
[TBL] [Abstract][Full Text] [Related]
42. [A study of p16 gene and its protein expression in rhabdomyosarcoma].
Gao Z; Zhang S; Yang G
Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):290-3. PubMed ID: 11245000
[TBL] [Abstract][Full Text] [Related]
43. Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs.
Lollini PL; De Giovanni C; Del Re B; Landuzzi L; Nicoletti G; Prodi G; Scotlandi K; Nanni P
Cancer Res; 1989 Jul; 49(13):3631-6. PubMed ID: 2471586
[TBL] [Abstract][Full Text] [Related]
44. Retroviral introduction of the p16 gene into murine cell lines to elicit marked antiproliferative effects.
Ikeda H; Yoshida J; Yamada H; Yoshimatsu T; Ikenaka K
Jpn J Cancer Res; 1997 Aug; 88(8):712-7. PubMed ID: 9330601
[TBL] [Abstract][Full Text] [Related]
45. Low sample volume causes differentiation in human rhabdomyosarcoma cell line RD subjected to electroporation.
Aránega A; Marchal JA; Melguizo C; Prados J; Aránega AE; Vélez C; Fernández JE; Arena N; Alvarez L
Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1219-27. PubMed ID: 8997525
[TBL] [Abstract][Full Text] [Related]
46. Differentiation of a human rhabdomyosarcoma cell line after antineoplastic drug treatment.
Melguizo C; Prados J; Aneiros J; Fernandez JE; Velez C; Aranega A
J Pathol; 1995 Jan; 175(1):23-9. PubMed ID: 7891223
[TBL] [Abstract][Full Text] [Related]
47. Loss of p16/Ink4a drives high frequency of rhabdomyosarcoma in a rat model of Duchenne muscular dystrophy.
Teramoto N; Ikeda M; Sugihara H; Shiga T; Matsuwaki T; Nishihara M; Uchida K; Yamanouchi K
J Vet Med Sci; 2021 Sep; 83(9):1416-1424. PubMed ID: 34334511
[TBL] [Abstract][Full Text] [Related]
48. [p16INK4a expression mediated by recombinant adenovirus can induce senescence of A549 cells].
Bai XY; Che FX; Chen XM; Meng LY; Zhou Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):54-8. PubMed ID: 15340528
[TBL] [Abstract][Full Text] [Related]
49. The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line.
Garvin AJ; Stanley WS; Bennett DD; Sullivan JL; Sens DA
Am J Pathol; 1986 Oct; 125(1):208-17. PubMed ID: 3777136
[TBL] [Abstract][Full Text] [Related]
50. Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation.
Quesnel B; Preudhomme C; Lepelley P; Hetuin D; Vanrumbeke M; Bauters F; Velu T; Fenaux P
Br J Haematol; 1996 Nov; 95(2):291-8. PubMed ID: 8904884
[TBL] [Abstract][Full Text] [Related]
51. Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.
De Giovanni C; Lollini PL; Dolcetti R; Landuzzi L; Nicoletti G; D'Andrea E; Scotland K; Nanni P
Br J Cancer; 1993 Apr; 67(4):674-9. PubMed ID: 8471424
[TBL] [Abstract][Full Text] [Related]
52. Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas.
Hiti AL; Bogenmann E; Gonzales F; Jones PA
Mol Cell Biol; 1989 Nov; 9(11):4722-30. PubMed ID: 2601695
[TBL] [Abstract][Full Text] [Related]
53. Exogenous expression of p16INK4a is associated with decrease in telomerase activity.
Sawa H; Kamada H; Ohshima TA; Noguchi A; Itoh N; Saruta K; Hara M; Saito I
J Neurooncol; 1999 Mar; 42(1):45-57. PubMed ID: 10360478
[TBL] [Abstract][Full Text] [Related]
54. MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.
Faggi F; Codenotti S; Poliani PL; Cominelli M; Chiarelli N; Colombi M; Vezzoli M; Monti E; Bono F; Tulipano G; Fiorentini C; Zanola A; Lo HP; Parton RG; Keller C; Fanzani A
PLoS One; 2015; 10(6):e0130287. PubMed ID: 26086601
[TBL] [Abstract][Full Text] [Related]
55. Homozygous deletion of the p16INK4A gene occurs more frequently in CD2+ than in CD2+ T-cell acute lymphoblastic leukemia.
Tien HF; Tang JL; Lee CF; Jou ST
Blood; 1998 Mar; 91(5):1829-30. PubMed ID: 9473253
[No Abstract] [Full Text] [Related]
56. Defective myogenic differentiation of human rhabdomyosarcoma cells is characterized by sialidase Neu2 loss of expression.
Stoppani E; Rossi S; Marchesini S; Preti A; Fanzani A
Cell Biol Int; 2009 Sep; 33(9):1020-5. PubMed ID: 19524683
[TBL] [Abstract][Full Text] [Related]
57. Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells.
De Giovanni C; Nanni P; Sacchi A; Soddu S; Manni I; D'Orazi G; Bulfone-Paus S; Pohl T; Landuzzi L; Nicoletti G; Frabetti F; Rossi I; Lollini PL
Br J Cancer; 1998 Dec; 78(12):1541-6. PubMed ID: 9862562
[TBL] [Abstract][Full Text] [Related]
58. Induction of myogenic differentiation in a human rhabdomyosarcoma cell line by phenylacetate.
Cinatl J; Cinatl J; Herneiz P; Rabenau H; Hovak M; Benda R; Gümbel HO; Kornhuber B; Doerr HW
Cancer Lett; 1994 Apr; 78(1-3):41-8. PubMed ID: 8180967
[TBL] [Abstract][Full Text] [Related]
59. Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602).
Marchal JA; Melguizo C; Prados J; Aránega AE; Gómez JA; Campos J; Gallo MA; Espinosa A; Arena N; Aránega A
Jpn J Cancer Res; 2000 Sep; 91(9):934-40. PubMed ID: 11011122
[TBL] [Abstract][Full Text] [Related]
60. Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.
Nicoletti G; De Giovanni C; Landuzzi L; Simone G; Rocchi P; Nanni P; Lollini PL
Br J Cancer; 1992 Apr; 65(4):519-22. PubMed ID: 1562460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
